ABEO: Abeona Therapeutics Inc.
Performance
ABEO -39.52%
Watchlist
Select an item
Summary
ABEO at a glance
ABEO returned -39.52% over the past year and -35.24% a year over five years. Its worst drop in that year was -65.95%, smaller than 8% of stocks on Redstone, and its Sharpe ratio of -0.44 beats 13% of stocks on Redstone. It pays no dividends.
Current Drawdown
-65.95%
Rolling Volatility
142.72%
Actions
Metrics
Risk Indicators
Alpha-39.17%
Beta1.01x
Sharpe-0.44
Sortino-0.55
Omega0.92
Calmar-0.60
Martin-1.66
Profile
About ABEO
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $145M
- Listed
- Sep 1980
- Employees
- 226
- Headquarters
- Cleveland, OH
- Website
- abeonatherapeutics.com
Comparisons